Renal Angiomyolipoma clinical trials at University of California Health

1 research study open to eligible people

Showing trials for

  • Simple-Prep Controlled Embolic

    open to eligible people ages 18 years and up

    The objective of this study is to evaluate the safety and effectiveness of the GPX® Embolic Device when used as indicated for embolization requiring distal vessel penetration in 114 subjects in up to 25 investigational sites in the USA, New Zealand, and Canada.

    at UCSD

Our lead scientists for Renal Angiomyolipoma research studies include .

Last updated: